About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Prostate Cancer Clinical Trials in Ohio | 521 Studies

Clinical Trials Prostate CancerOhio

Prostate Cancer Clinical Trials in Ohio

Find 521 clinical trials for prostate cancer near Ohio. Connect with research centers in your area.

All Prostate Cancer trials nationwide All trials in Ohio

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 141-160 of 521 trials

CompletedExternal-Beam Radiation Therapy Plus Implanted Radiation Therapy in Treating Patients With Prostate CancerRATIONALE: Radiation therapy uses high-energy x-rays and other sources to damage tumor cells. Giving radiation therapy in different ways may kill more tumor cells.NCT00006365·Birmingham, Alabama and 253 others

Prostate Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

RecruitingComprehensive Outcomes for After Cancer HealthThis study intends to explore feasibility, acceptability, and outcomes related to the use of a digital health coaching intervention for individuals who have completed primary…NCT05349227·Gainesville, Florida and 6 others

Active not recruiting177Lu-PSMA-I&T for Metastatic Castration-Resistant Prostate CancerA Multi-Center, Open-Label, Randomized Phase 3 Trial Comparing the Safety and Efficacy of 177Lu-PSMA-I\&T versus Hormone Therapy in Patients with Metastatic Castration-Resistant…NCT05204927·Tucson, Arizona and 51 others

CompletedOpen Label Study of Sipuleucel-T in Metastatic Prostate CancerThis is a Multicenter, Open Label, Phase 2 Study of Sipuleucel-T in Men with Metastatic Castrate Resistant Prostate Cancer (CRPC).NCT00901342·Washington D.C., District of Columbia and 17 others

CompletedAvelumab in Metastatic or Locally Advanced Solid Tumors (JAVELIN Solid Tumor)This is a Phase 1, open-label, dose-escalation trial of avelumab \[antibody targeting programmed death ligand 1 (anti PD-L1)\] with consecutive parallel group expansion in…NCT01772004·Goodyear, Arizona and 73 others

TerminatedA Trial Comparing Cardiovascular Safety of Degarelix Versus Leuprolide in Patients With Advanced Prostate Cancer and Cardiovascular DiseaseThe purpose of this trial is to test if a marketed drug for advanced prostate cancer (FIRMAGON) can reduce the risk of cardiovascular complications as compared to another marketed…NCT02663908·Birmingham, Alabama and 132 others

CompletedApalutamide and Leuprolide in Intermediate and High-risk Prostate CancerThis is a research study to test an investigational drug (Not FDA approved), Apalutamide given in combination with Leuprolide acetate (FDA approved) in men diagnosed with…NCT02770391·Cleveland, Ohio

TerminatedMicrospheres in Preventing Lymphatic Fluid Collection After Surgery in Patients With Prostate CancerThis study is being performed to investigate if the application of Arista absorbable hemostat (AH)®, a product approved to stop surgical bleeding, can prevent lymphoceles.NCT01644136·Columbus, Ohio

WithdrawnStudy of a Drug [DCVax (tm)-Prostate] to Treat Prostate Cancer When Hormone Therapy is no Longer Effective.The purpose of this clinical research study is to assess the safety and efficacy of an investigational therapy called DCVax(TM)-Prostate.NCT00043212·Springdale, Arkansas and 15 others

CompletedGemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract CancerThis randomized phase III trial studies gemcitabine hydrochloride, cisplatin, and bevacizumab to see how well they work compared with gemcitabine hydrochloride and cisplatin in…NCT00942331·Birmingham, Alabama and 872 others

TerminatedEffect of GTx-758 on Total and Free Testosterone Levels in Men With Prostate CancerThe purpose of this study is to determine whether GTx 758 is effective in achieving and maintaining castrate testosterone levels in men with advanced prostate cancer.NCT01326312·Phoenix, Arizona and 35 others

RecruitingA Study of SYNC-T Therapy SV-102 in Participants With Metastatic Castration-Resistant Prostate CancerThe primary purpose of this study is to evaluate the safety, tolerability, and efficacy of SYNC-T Therapy SV-102 and to identify the maximum tolerated dose (MTD) and/or selected…NCT06533644·Phoenix, Arizona and 22 others

No longer availableRadium-223 Dichloride (BAY88-8223) in Castration-Resistant (Hormone-Refractory) Prostate Cancer Patients With Bone MetastasesThis study is a prospective, interventional, open-label, multi-center early access program for the use of Ra-223 Cl2 in HRPC/CRPC patients diagnosed with symptomatic bone…NCT01516762·Birmingham, Alabama and 59 others

TerminatedTo Evaluate Safety and Tolerability of VERU-111 in Men With Advanced Metastatic Castration Resistant Prostate CancerPhase 1b - To assess the safety/tolerability of VERU-111 and to determine the maximum tolerated dose of VERU-111 in patients with metastatic, castration resistant prostate cancer…NCT03752099·Golden, Colorado and 12 others

RecruitingA Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and LymphomasThe purpose of this open-label, first-in-human (FIH) trial is to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, and preliminary antitumor activity of…NCT04104776·Tampa, Florida and 79 others

TerminatedLeuvectin in Treating Patients With Locally Recurrent Prostate CancerRATIONALE: Inserting the gene for interleukin-2 into a person's prostate cancer cells may make the body build an immune response to kill tumor cells.NCT00005072·Los Angeles, California and 1 other

TerminatedPhase II, Dose Finding Study of GTx-758The purpose of this study is to determine the appropriate loading and maintenance dose of GTx-758 to reach and maintain castration for the duration of the study.NCT01393119·Glendale, Arizona and 20 others

CompletedThe Safety and Tolerability of GT0918 in Subjects With mHSPC and mCRPCThis was a multiple-center, open-label, randomized, daily dose, two-sequence, expanded/phase II study in subjects with mHSPC or mCRPC who progressed after either abiraterone or…NCT03899467·Athens, Georgia and 9 others

CompletedStudy of Blood Samples From Older Patients at High Risk of Developing Prostate Cancer and From Healthy Male ParticipantsRATIONALE: Studying samples of blood in the laboratory from patients who are at high risk of developing prostate cancer may help doctors identify biomarkers related to cancer.NCT00898274·Cleveland, Ohio and 2 others

CompletedSafety and Efficacy Study of Enzalutamide in Patients With Nonmetastatic Castration-Resistant Prostate CancerThe purpose of this study is to assess the safety and efficacy of enzalutamide in patients with non metastatic prostate cancer.NCT02003924·Tucson, Arizona and 396 others

PreviousPage 8 of 27Next

Other Conditions in Ohio

Breast Cancer Lung Cancer Colorectal Cancer Melanoma Leukemia Lymphoma